Consumers with time on their hands at home have become better researched about plant-derived ingredients that deliver results, which, according to Lodaat Pharmaceuticals, is where cosmeceuticals are headed. Cosmeceutical possibilities and regulatory complexities were the substance of a panel discussion at CPhI Worldwide, featuring Lodaat director Rajiv Khatau and EAS Consulting’s John Bailey.

Office of Cosmetics and Colors Linda Katz emphasizes FDA sees allergen labeling as a public health issue. While many allergic reactions are minor, “consumers who are extremely or exclusively sensitive to a particular ingredient should have a right to know.”

CIR’s work is far from done, says executive director Bart Heldreth, citing the cosmetics industry's vibrant innovation tradition and ingredient re-review needs that should keep the program sufficiently busy.